
Multiomic Health is a precision medicine company focused on metabolic syndrome-derived diseases, including diabetes, chronic kidney disease, atherosclerosis, and non-alcoholic fatty liver disease. They utilize a unique combination of longitudinal patient datasets, AI-enabled data science, and experimental biology to identify patient subpopulations with distinct molecular drivers. This approach allows them to originate and pursue therapeutic R&D programs with corresponding patient-stratifying biomarkers, aiming for shorter and more successful clinical trials. Their business model involves developing therapeutics and companion diagnostics, with approved drugs to be marketed by pharmaceutical partners. They also commission laboratory service providers for LDT and IVD tests.

Multiomic Health is a precision medicine company focused on metabolic syndrome-derived diseases, including diabetes, chronic kidney disease, atherosclerosis, and non-alcoholic fatty liver disease. They utilize a unique combination of longitudinal patient datasets, AI-enabled data science, and experimental biology to identify patient subpopulations with distinct molecular drivers. This approach allows them to originate and pursue therapeutic R&D programs with corresponding patient-stratifying biomarkers, aiming for shorter and more successful clinical trials. Their business model involves developing therapeutics and companion diagnostics, with approved drugs to be marketed by pharmaceutical partners. They also commission laboratory service providers for LDT and IVD tests.